J Korean Assoc Oral Maxillofac Surg.  2023 Dec;49(6):309-310. 10.5125/jkaoms.2023.49.6.309.

Understanding of oral potentially malignant disorders and epithelial dysplasia among oral and maxillofacial surgeons

• Choi SY

• KMID: 2550293
• DOI: http://doi.org/10.5125/jkaoms.2023.49.6.309

Reference

References

1. Reibel J, Tilakaratne W, Gale N, Westra W, Hille J, Williams M, et al. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. 2017. Oral potentially malignant disorders & oral epithelial dysplasia. WHO classification of head and neck tumours. 4th ed. International Agency for Research on Cancer;p. 112–5.

2. Muller S, Tilakaratne WM. 2022; Update from the 5th edition of the World Health Organization classification of head and neck tumors: tumours of the oral cavity and mobile tongue. Head Neck Pathol. 16:54–62. https://doi.org/10.1007/s12105-021-01402-9. DOI: 10.1007/s12105-021-01402-9. PMID: 35312982. PMCID: PMC9018914.

3. Neville BW, Damm DD, Allen CM, Chi AC. 2023. Oral and maxillofacial pathology. 5th ed. Elsevier;p. 380–1.

4. Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, et al. 2020; Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 42:539–55. https://doi.org/10.1002/hed.26006. DOI: 10.1002/hed.26006. PMID: 31803979.

5. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. 2006; Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 42:987–93. https://doi.org/10.1016/j.oraloncology.2005.12.014. DOI: 10.1016/j.oraloncology.2005.12.014. PMID: 16731030.

6. Mehanna HM, Rattay T, Smith J, McConkey CC. 2009; Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck. 31:1600–9. https://doi.org/10.1002/hed.21131. DOI: 10.1002/hed.21131. PMID: 19455705.

7. Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, et al. 2020; Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study. J Natl Cancer Inst. 112:1047–54. https://doi.org/10.1093/jnci/djz238. DOI: 10.1093/jnci/djz238. PMID: 31860085. PMCID: PMC7566351.

8. Yan F, Reddy PD, Nguyen SA, Chi AC, Neville BW, Day TA. 2020; Grading systems of oral cavity pre-malignancy: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 277:2967–76. https://doi.org/10.1007/s00405-020-06036-1. DOI: 10.1007/s00405-020-06036-1. PMID: 32447493.

9. Awadallah M, Idle M, Patel K, Kademani D. 2018; Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 125:628–36. https://doi.org/10.1016/j.oooo.2018.03.010. DOI: 10.1016/j.oooo.2018.03.010. PMID: 29656948.

10. Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. 2012; Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med. 41:682–8. https://doi.org/10.1111/j.1600-0714.2012.01167.x. DOI: 10.1111/j.1600-0714.2012.01167.x. PMID: 22697318.